Botanical Therapy Development
Standardization and FDA ready materials Formulation and manufacturing in weeks, not months. We Handle CMC, Regulatory and Compliance. From Grant to Commercialization.
Pre-clinical and Clinical Trial Expertise
We partner with universities and researchers looking to run well controlled and reproducible studies by providing an operational backbone.
Sym Sciences enables your work to progress from early stages toward publication and real world implementation
- Standardized Materials
- Chemistry, Manufacturing, and Controls (CMC) Documentation
- Investigational New Drug (IND) Preparation
- Regulatory Coordination
Domestic Supply Chain
US-based, medical-grade botanical materials, to ensure high-quality, secure supply chains, traceability and support domestic
We leverage a fully compliant u.s. supply chain to support your research at every phase.
For Universities & Research Teams
View programs by phase, requirements, and participation pathways.
For Commercial Partners & Investors
Evaluate later-stage opportunities and commercialization pathways.
Sym News
Symplifying Science
Symplifying Science
From IND to commercialization — we handle supply chain, CMC, regulatory filings, and quality assurance so researchers can focus on science.
Learn more- Sym's Solutions
Materials
Reproducible & auditable cGMP manufacturing supply chain built for scale. We utilize domestically sourced ingredients to ensure compliance and continuity.
Our experts assist in formulation development and prepare all required documentation to ensure the investigational ingredients are standardized and compliant for current and future studies.
Regulatory
We support IND submissions through nonclinical and clinical evidence review, CMC preparation, protocol support, ISO/IEC 17025 testing, and additional regulatory services.
We lead FDA-related communications in collaboration with qualified regulatory experts and support university IRB processes following IND authorization.
Commercialization
We collaborate with healthcare organizations across research, clinical, and commercial domains to align stakeholders from seed-stage development through clinical studies and market adoption
While we provide a broad range of services, we have also developed and continue to advance our research roadmap of high-potential therapeutic programs, supported by our infrastructure and expertise in drug development.
We standardize the core research infrastructure– including materials, documentation, and regulatory controls– so partners can move faster while maintaining the integrity required for publication, funding, and commercialization.
Researchers frequently approach us to help develop and supply study-specific materials, informed by existing preclinical and clinical data. By aligning formulation development with validated study designs, we provide unique formulation solutions that are tailored to the target outcomes of each study.
We help ensure formulations are optimized for the target indication, minimizing avoidable setbacks in your research.
The FDA pathway for complex botanical products remains largely unresolved, with significant scientific and regulatory questions still open. At Sym Sciences, we do not treat this uncertainty as a barrier, rather an ecosystem that requires disciplined, process-driven innovation.
Our work begins with identifying problems grounded in scientific, regulatory and market context. We then work with our partner universities, researchers, clinicians and other research programs to design studies guided by the project objective.
Sym Sciences’ integrated system brings together multidisciplinary expertise to develop study-specific materials, study design, and translational relevance to streamline projects for success. Our role is not to provide fixed conclusions, but to build the infrastructure that enables high-quality science to answer them.
- For Researchers
EXECUTE AUDIT-READY STUDIES
- For Investors & Commercialization
2026
PROGRAMS BUILT FOR COMMERCIALIZATION
A compliant operational backbone for botanical trials
Universities and research teams shouldn’t need to become regulatory or supply-chain organizations to run high-integrity studies.
Sym Sciences provides the infrastructure—controlled materials, CMC documentation, QA/QC systems, and regulatory coordination—so research remains the focus.
Our job is to remove friction
without reducing rigor.
